Apyx Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.3% | -9.6% | -5.2% | -3.9% | +12.7% | +17.6% | +1.8% | -1.4% | -22.2% | -13.4% | +9.3% | |
| – | +48.2% | +40.7% | +7.7% | +75.1% | +134.8% | +17.6% | +20.9% | +31.6% | -23.6% | -21.5% | -50.1% | |
| – | -108.6% | – | +12.9% | -5,812.2% | – | +41.8% | +7.4% | +27.0% | – | – | – | |
| – | -104.4% | – | – | – | – | – | – | – | – | -122.5% | – | |
| – | -33.2% | -32.1% | +118.2% | -41.8% | +258.4% | -55.3% | +24.4% | +39.7% | -47.2% | +35.5% | +54.3% | |
| – | +46.2% | -68.9% | +118.2% | – | +106.6% | -101.0% | +24.4% | +39.7% | – | -110.7% | +54.3% | |
| – | – | -55.0% | – | – | +2.5% | -28.5% | +31.8% | – | – | – | – | |
| – | -107.9% | +0.6% | -0.6% | +1,405.0% | -97.8% | +515.0% | -35.5% | -37.8% | – | -100.1% | +0.0% | |
| – | – | -54.8% | -103.1% | +1,292.2% | – | -149.7% | – | +804.2% | +14,723.0% | -79.0% | +42.0% | |
| – | – | -56.3% | -270.0% | – | +628.1% | -140.0% | – | – | – | -135.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.